Skip to main content

About this Research Topic

Submission closed.

In all organisms, the DNA replication machinery is responsible for accurate and efficient duplication of the chromosome. Inhibitors of replication proteins are commonly used in anti-cancer and anti-viral therapies. This Research Topic will examine the normal functions of replication proteins and strategies to ...

In all organisms, the DNA replication machinery is responsible for accurate and efficient duplication of the chromosome. Inhibitors of replication proteins are commonly used in anti-cancer and anti-viral therapies. This Research Topic will examine the normal functions of replication proteins and strategies to target each step during the replication process including helicases, replication and lesion bypass DNA polymerases, topoisomerases and DNA repair enzymes. Articles will discuss current strategies to develop drugs targeting DNA replication proteins as well as future outlooks and needs.

Keywords: DNA replication, DNA polymerase, DNA helicase, topoisomerase, anti-cancer therapies, anti-viral therapies, translesion DNA polymerase, nucleoside inhibitors, mitochondrial DNA polymerase


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Topic Editors

Loading..

Topic Coordinators

Loading..

Recent Articles

Loading..

Articles

Sort by:

Loading..

Authors

Loading..

views

total views views downloads topic views

}
 
Top countries
Top referring sites
Loading..

Share on

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.